These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16092577)

  • 1. Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study.
    Pena de la Vega L; Miller RS; Benda MM; Grill DE; Johnson MG; McCarthy JT; McBane RD
    Mayo Clin Proc; 2005 Aug; 80(8):995-1000. PubMed ID: 16092577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia in hemodialysis patients.
    Yamamoto S; Koide M; Matsuo M; Suzuki S; Ohtaka M; Saika S; Matsuo T
    Am J Kidney Dis; 1996 Jul; 28(1):82-5. PubMed ID: 8712226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.
    Baroletti S; Hurwitz S; Conti NA; Fanikos J; Piazza G; Goldhaber SZ
    Am J Med; 2012 Jan; 125(1):44-9. PubMed ID: 22075045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
    Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
    Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex.
    Carrier M; Rodger MA; Fergusson D; Doucette S; Kovacs MJ; Moore J; Kelton JG; Knoll GA
    Kidney Int; 2008 Jan; 73(2):213-9. PubMed ID: 17943076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients.
    Boonyawat K; Angchaisuksiri P; Aryurachai K; Chaiyaroj S; Ahmadi Z; Chong BH
    Thromb Res; 2014 Nov; 134(5):957-62. PubMed ID: 25204999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up.
    Zhao D; Sun X; Yao L; Lin H; Li J; Zhao J; Zhang Z; Lun L; Zhang J; Li M; Huang Q; Yang Y; Jiang S; Wang Y; Zhu H; Chen X
    PLoS One; 2013; 8(4):e62239. PubMed ID: 23646121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
    Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
    Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients.
    Tsai YF; Chen CA; Kuo C; Lin KC
    Clin Exp Nephrol; 2012 Apr; 16(2):300-5. PubMed ID: 22038266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis.
    Tanhehco YC; Cuker A; Rudnick M; Sachais BS
    Thromb Res; 2013 Mar; 131(3):244-8. PubMed ID: 23305841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia.
    Sylvester KW; Fanikos J; Anger KE; Matta L; Southard RA; Beik N; Lemire SJ; Dorfman DM; Berliner N
    Pharmacotherapy; 2013 Nov; 33(11):1191-8. PubMed ID: 23813781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-platelet factor 4/heparin antibody is associated with progression of peripheral arterial disease in hemodialysis patients.
    Chen YH; Lin KC; Tsai YF; Yu LK; Huang LH; Chen CA
    Int Urol Nephrol; 2015 Sep; 47(9):1565-70. PubMed ID: 26198856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.
    Chang JJ; Parikh CR
    Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.